Quest Diagnostics Incorporated
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $126.445
- Today's High:
- $127.65
- Open Price:
- $126.75
- 52W Low:
- $118.6274
- 52W High:
- $156.8483
- Prev. Close:
- $126.71
- Volume:
- 537168
Company Statistics
- Market Cap.:
- $15.03 billion
- Book Value:
- 54.018
- Revenue TTM:
- $9.60 billion
- Operating Margin TTM:
- 14.07%
- Gross Profit TTM:
- $3.47 billion
- Profit Margin:
- 8.26%
- Return on Assets TTM:
- 6.44%
- Return on Equity TTM:
- 13.57%
Company Profile
Quest Diagnostics Incorporated had its IPO on 1996-12-17 under the ticker symbol DGX.
The company operates in the Healthcare sector and Diagnostics & Research industry. Quest Diagnostics Incorporated has a staff strength of 40,000 employees.
Stock update
Shares of Quest Diagnostics Incorporated opened at $126.75 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $126.45 - $127.65, and closed at $127.23.
This is a +0.41% increase from the previous day's closing price.
A total volume of 537,168 shares were traded at the close of the day’s session.
In the last one week, shares of Quest Diagnostics Incorporated have slipped by -2.52%.
Quest Diagnostics Incorporated's Key Ratios
Quest Diagnostics Incorporated has a market cap of $15.03 billion, indicating a price to book ratio of 2.7602 and a price to sales ratio of 1.6509.
In the last 12-months Quest Diagnostics Incorporated’s revenue was $9.60 billion with a gross profit of $3.47 billion and an EBITDA of $1.79 billion. The EBITDA ratio measures Quest Diagnostics Incorporated's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Quest Diagnostics Incorporated’s operating margin was 14.07% while its return on assets stood at 6.44% with a return of equity of 13.57%.
In Q1, Quest Diagnostics Incorporated’s quarterly earnings growth was a negative -39% while revenue growth was a negative 10.7%.
Quest Diagnostics Incorporated’s PE and PEG Ratio
- Forward PE
- 17.4825
- Trailing PE
- 19.424
- PEG
- 1.2373
Its diluted EPS in the last 12-months stands at $6.91 per share while it has a forward price to earnings multiple of 17.4825 and a PEG multiple of 1.2373. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Quest Diagnostics Incorporated’s profitability.
Quest Diagnostics Incorporated stock is trading at a EV to sales ratio of 2.0546 and a EV to EBITDA ratio of 9.5916. Its price to sales ratio in the trailing 12-months stood at 1.6509.
Quest Diagnostics Incorporated stock pays annual dividends of $2.69 per share, indicating a yield of 2.12% and a payout ratio of 30.78%.
Balance sheet and cash flow metrics
- Total Assets
- $12.79 billion
- Total Liabilities
- $1.36 billion
- Operating Cash Flow
- $-158000000.00
- Capital Expenditure
- $127 million
- Dividend Payout Ratio
- 30.78%
Quest Diagnostics Incorporated ended 2024 with $12.79 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $12.79 billion while shareholder equity stood at $6.05 billion.
Quest Diagnostics Incorporated ended 2024 with $0 in deferred long-term liabilities, $1.36 billion in other current liabilities, 2000000.00 in common stock, $8.41 billion in retained earnings and $7.24 billion in goodwill. Its cash balance stood at $175.00 million and cash and short-term investments were $175.00 million. The company’s total short-term debt was $157,000,000 while long-term debt stood at $3.98 billion.
Quest Diagnostics Incorporated’s total current assets stands at $1.81 billion while long-term investments were $128.00 million and short-term investments were $0. Its net receivables were $1.25 billion compared to accounts payable of $1.20 billion and inventory worth $190.00 million.
In 2024, Quest Diagnostics Incorporated's operating cash flow was $-158000000.00 while its capital expenditure stood at $127 million.
Comparatively, Quest Diagnostics Incorporated paid $0.31 in dividends in 2024.
Other key metrics
- Current Trading Price
- $127.23
- 52-Week High
- $156.8483
- 52-Week Low
- $118.6274
- Analyst Target Price
- $147.6
Quest Diagnostics Incorporated stock is currently trading at $127.23 per share. It touched a 52-week high of $156.8483 and a 52-week low of $156.8483. Analysts tracking the stock have a 12-month average target price of $147.6.
Its 50-day moving average was $135.37 and 200-day moving average was $139.65 The short ratio stood at 3.78 indicating a short percent outstanding of 0%.
Around 83.1% of the company’s stock are held by insiders while 9297.1% are held by institutions.
Frequently Asked Questions About Quest Diagnostics Incorporated
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.